Hinterhaus Productions via Getty Images Shares of Edgewise Therapeutics fell sharply Wednesday after the company released data for its latest clinical trial. The drug accomplished its main goal ...

Edgewise has said that EDG-7500 can reduce left ventricular outflow tract gradients and improve diastolic relaxation without impairing ejection fraction. While the company maintains that these ...

Edgewise Therapeutics (NASDAQ:EWTX) was downgraded to Sector Perform from prior Sector Outperform at Scotiabank after results from the company's mid-stage trial for its heart disease therapy EDG ...

Leerink Partners, Piper Sandler, Guggenheim Securities and Truist Securities acted as joint book-running managers for the offering. Edgewise intends to use the net proceeds from the offering to ...

Edgewise Therapeutics (NASDAQ:EWTX) fell 10.6% in premarket trade after it priced its offering to raise $200 million. The firm priced its underwritten offering of 9.9M shares at $20.13 apiece ...

Edgewise Therapeutics' hypertrophic cardiomyopathy (HCM) asset has resulted in “rapid and clinically meaningful” reductions of a measure of obstruction of the heart’s valves. The biotech has ...

It has become almost impossible to book a driving test on the government website due to bots on the booking system, driving instructors have told Sky News. The only official way to book a ...

Edgewise Therapeutics shares are trading lower by 23.3% during Wednesday's session. The company announced an approximate $200 million offering. China’s new tariffs just reignited the same ...

Extreme adventurer Mark Synnott is out with his third book, chronicling his attempt to sail through the Northwest Passage in ...

Leerink Partners, Piper Sandler, Guggenheim Securities and Truist Securities acted as joint book-running managers for the offering. Edgewise intends to use the net proceeds from the offering to ...

Lynn Steger Strong’s exquisitely written fourth novel, “The Float Test,” is a piercing portrait ... the whole business of being a writer; the books have alienated her from family and friends ...

Also Read: Edgewise Therapeutics’ Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease In September 2024, the company announced topline data from ...